Companies / Structure Therapeutics Inc. / Activity
Activity — Structure Therapeutics Inc.
71 moves.
Top impactInsider · CEO movesInsider · biggest buysInsider · biggest sellsInstitution · biggest movesInstitution · new positions
| Date | Actor | Action | Security | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|---|
| Q1 2026 as of | TD Asset Management Inc 13F manager | Add | ADR | $1.45M | +30K +17.23% | 204,762 0.10% of shares | low |
| Q1 2026 as of | Capital Fund Management S.A. 13F manager | New | ADR | $1.56M | +32K | 32,436 0.02% of shares | low |
| Q2 2024 as of | Barclays PLC 13F manager | Trim | ADR | $-1.61M | -41K -50.50% | 40,223 0.02% of shares | low |
| Q3 2024 as of | Barclays PLC 13F manager | Add | ADR | $1.80M | +41K +101.72% | 81,138 0.04% of shares | low |
| Q1 2025 as of | Barclays PLC 13F manager | Trim | ADR | $-1.91M | -110K -95.41% | 5,312 <0.01% of shares | low |
| Q1 2026 as of | Pacific Heights Asset Management LLC 13F manager | Add | ADR | $2.41M | +50K +7.14% | 750,000 0.35% of shares | low |
| Q1 2026 as of | Renaissance Technologies LLC 13F manager | Trim | ADR | $-2.86M | -59K -51.56% | 55,800 0.03% of shares | low |
| Q1 2026 as of | HighVista Strategies LLC 13F manager | Trim | ADR | $-3.33M | -69K -35.80% | 123,909 0.06% of shares | low |
| Q1 2024 as of | Barclays PLC 13F manager | Add | ADR | $3.45M | +80K +9667.07% | 81,262 0.04% of shares | low |
| Q1 2026 as of | Two Sigma Investments, LP 13F manager | Add | ADR | $4.14M | +86K +89.88% | 181,415 0.08% of shares | low |
| Q1 2026 as of | Balyasny Asset Management L.P. 13F manager | Add | ADR | $4.28M | +89K +41.04% | 304,934 0.14% of shares | low |
| Q2 2026 as of | BlackRock, Inc. 13F manager | Add | ADR | $4.35M | +81K +18.85% | 511,149 0.24% of shares | low |
| Q1 2026 as of | Marshall Wace, LLP 13F manager | Trim | ADR | $-4.79M | -99K -59.01% | 69,107 0.03% of shares | low |
| Q4 2025 as of | Boxer Capital Management, LLC 13F manager | New | ADR | $5.22M | +75K | 75,000 0.04% of shares | medium |
| Q1 2026 as of | D. E. Shaw & Co., Inc. 13F manager | Add | ADR | $9.46M | +196K +2274.93% | 204,790 0.10% of shares | medium |
| Q1 2026 as of | Janus Henderson Group PLC 13F manager | Add | ADR | $12.77M | +265K +5.20% | 5,354,981 2.50% of shares | medium |
| Q1 2026 as of | AllianceBernstein L.P. 13F manager | Trim | ADR | $-14.61M | -210K -24.74% | 638,813 0.30% of shares | medium |
| Q1 2026 as of | Orbimed Advisors LLC 13F manager | Add | ADR | $15.12M | +314K +26.99% | 1,475,403 0.69% of shares | medium |
| Q1 2026 as of | Principal Financial Group Inc 13F manager | Add | ADR | $22.63M | +470K +36.56% | 1,753,764 0.82% of shares | medium |
| Q2 2026 as of | Deutsche Bank AG 13F manager | Trim | ADR | $-27.33M | -509K -60.55% | 331,867 0.16% of shares | medium |
| Q4 2025 as of | Farallon Capital Management LLC 13F manager | New | ADR | $31.58M | +454K | 454,000 0.21% of shares | medium |